Is a DSM-5 diagnosis required to receive gender care?

In Dutch specialized gender care, the diagnosis is generally made as part of the pathway. For reimbursement by insurers, a valid diagnosis is often a requirement.

How does the DSM-5 differ from the ICD-11 on this point?

The DSM-5 still places gender dysphoria within a psychiatric framework. The ICD-11 has moved gender variation to a new chapter on sexual health and no longer considers it a mental disorder.

Home › Medical › DSM-5 and gender dysphoria

DSM-5 and gender dysphoria

Q: Why is it now called gender dysphoria and no longer gender identity disorder?

The name change in the DSM-5 (2013) emphasizes that gender identity itself is not a disorder, but the distress that may arise from the discrepancy.

The DSM-5, the diagnostic manual of the American Psychiatric Association, describes gender dysphoria as clinically significant distress arising from a discrepancy between experienced gender identity and birth sex. In 2013 the diagnosis replaced the earlier term 'gender identity disorder'. That name change was not primarily scientifically motivated but followed political and activist pressure to make the classification less stigmatising — a shift that also had substantive consequences for how the condition is approached.

From disorder to dysphoria: a political decision

By shifting the focus from the identity to the suffering, it was implicitly accepted that the gender identity itself may not be regarded as an anomaly. At the same time the diagnosis remained necessary for access to reimbursed medical care. The result is a contradictory construction: a condition that is formally not a disorder of the identity, but whose treatment consists of far-reaching bodily adjustment to that identity. Critics point out that this has held back wider research into causes and alternative treatments.

Diagnostic criteria

For adults and adolescents the DSM-5 requires a persistent discrepancy (at least six months) between experienced gender and biological sex, with clinically significant distress or functional impairment. Additional criteria apply in children. The criteria are broad and rest largely on self-report; there is no objective test. Two clinicians can reach different conclusions on the basis of the same conversation.

Validity and reliability: weak foundation

The empirical underpinning of the diagnosis is limited. There is no biomarker, no neurological test and no objective cut-off. The variation among those presenting is large: a 35-year-old man with lifelong dysphoria differs fundamentally from a 14-year-old girl who, after social-media use, suddenly identifies as a boy — yet both receive the same diagnosis. This heterogeneity undermines clinical usefulness.

Diagnosis as gateway to irreversible care

A DSM-5 diagnosis opens the door in the Netherlands to hormones and surgery, interventions with lifelong consequences for fertility, sexual function and bodily health. With a diagnosis with such a weak validity basis, that is a high risk. The Cass Review (2024) criticised precisely this trajectory: weak diagnostics lead too directly to heavy interventions.

DSM-5-TR (2022): cosmetic adjustments

The 2022 text revision (DSM-5-TR) left the criteria virtually unchanged in substance, but adjusted language and terminology in line with activist preferences ('sex assigned at birth' instead of 'biological sex'). The underlying question — when is dysphoria pathology, when is it variation, and when is medical intervention justified — remained unanswered.

DSM-5 versus ICD-11

The ICD-11 went one step further and moved gender variation entirely out of the psychiatric classification into a chapter on sexual health, without distress any longer being required. The access criterion is thereby further weakened. See also ICD-11 and gender variation.

Why is it now called gender dysphoria and no longer gender identity disorder?

Is the DSM-5 diagnosis objective?

Is a DSM-5 diagnosis required for gender care?

What is the difference with the ICD-11?